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Objective: HIV in Nicaragua is concentrated among key populations (KPs) – men who 
have sex with men, female sex workers, and female transgender – in whom prevalence 
is 600–4,000 times higher than the general population. The United States Agency for 
International Development PrevenSida project is aimed at increasing healthy behavior 
among KPs and people with HIV and improving testing, counseling, and continuity 
of prevention and treatment by building capacity and improving performance of non-
governmental organizations (NGOs) providing services to KPs. We evaluated the cost-
effectiveness of PrevenSida’s activities.
Methods: This retrospective observational evaluation used individuals in KPs covered 
by NGOs receiving assistance from PrevenSida from 2012 to 2014. Cost-effectiveness 
analysis compared PrevenSida’s intervention with business-as-usual. Model inputs were 
generated from epidemiological modeling and PrevenSida’s records.
results: By 2014, 24 NGOs received grants and technical assistance from PrevenSida 
with 72,955 people in KPs served at $11.32/person ($9.39–$16.55/person, depending 
on region). The estimated incremental cost-effectiveness ratio was $50,700/HIV case 
averted or $2,600/Disability-adjusted Life Year (DALY) averted (95% CI: $1,000–$99,000 
and $50–$5,100, respectively).
conclusion: PrevenSida distributed about $600,000 in grants and used $230,000 to 
support 24 NGOs in 2014. Cost-effectiveness from the program perspective compared 
to no program was slightly over half of GDP per capita per DALY averted, considered 
highly cost-effective by WHO criteria. Cost and efficiency varied by region, reflecting 
the number of people in KPs receiving services. Cost-sharing by NGOs improved cost-
effectiveness from the program perspective and likely promotes sustainability. Focused 
interventions for KP service provision organizations can be acceptably efficient in this 
setting.
Keywords: vulnerable populations, hiV infections, nicaragua, cost efficiency analysis
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inTrODUcTiOn
Cases of HIV in Nicaragua are concentrated among groups of 
individuals referred to as key populations (KPs), such as men who 
have sex with men (MSM), female sex workers (FSW), and female 
transgender people (FT). In 2013, HIV prevalence among MSM 
was 7.5%, among FSW was 1.9%, and among FT was 13.8% (1), 
whereas in the general population it was 0.003% (2).
To control the country’s epidemic, the United States Agency 
for International Development (USAID) Nicaragua has funded 
the PrevenSida Project to reach KPs through building capacity 
and improving performance of Nicaraguan non-governmental 
organizations (NGOs) that provide services to KPs. PrevenSida 
is a 6-year project aimed at increasing healthy behavior among 
those most at risk of HIV/AIDS transmission. Its goals are to 
strengthen institutional capacities of NGOs working with KPs, 
improve access to and quality of HIV/AIDS preventive services, 
reduce stigma and discrimination among KPs, and improve 
coverage of KPs by NGOs. The project grants funds to KP 
NGOs and works to improve data quality and continuity of care 
for those with HIV. To encourage sustainability, PrevenSida 
requires participating NGOs to use material support from 
sources outside the project, including in-kind donations of HIV 
test kits, condoms and lubricants, administrative resources use 
such as buildings and capital equipment, and in-kind donations 
of labor.
It is important for the Nicaraguan Ministry of Health, 
USAID, and the United States President’s Emergency Plan for 
AIDS Relief (PEPFAR) to know the efficiency and effectiveness 
of the activities implemented by PrevenSida, especially as 
PEPFAR pivots toward service providers in geographic areas 
with high burden and focuses on transparency, accountability 
for impact, and accelerating core interventions for epidemic 
control (3).
An external evaluation of bilateral USAID programing, which 
included assessment of the PrevenSida Project, was commis-
sioned by USAID and conducted in 2014 (1). It showed success 
in capacity-building for key organizations involved with the 
response to HIV and good communication and coordination 
between them. However, there was no examination of the cost 
of the combination prevention model for KPs and no evaluation 
of efficiency of capacity development for NGOs. The current 
study evaluates the cost-effectiveness of the PrevenSida activities 
in terms of expenditure per additional KP individual receiving 
services from a supported NGO, per case of HIV averted, and per 
disability-adjusted Life Year (DALY) averted. It estimates the cost 
and efficiency of nationwide expansion and consolidation of this 
prevention approach.
research Questions
The questions for this evaluation are:
 1. What is the cost and efficiency of the prevention program 
implemented by PrevenSida in terms of the projected propor-
tion of HIV infections averted?
 2. What is the cost-effectiveness, in terms of DALYs averted, of 
the PrevenSida intervention?
intervention
PrevenSida provided technical assistance using principles of 
quality improvement to develop human resources competencies 
in preventive service provision, community outreach, and general 
management. It worked to address accessibility gaps in KPs and 
developed a combined prevention model based on working with 
the civil society organization networks in their own social spaces 
and complementing public services (4).
Following project start-up in 2011, the intervention was fully 
underway by 2012 when 12 NGOs were receiving technical 
support. Capacity development for NGO management included 
organizing boards of directors, defining overall strategic and 
annual plans, developing internal accountability and budget 
formulation and management, and formulating overall monitor-
ing systems. For service provision activities, a computer-based 
monitoring and epidemiological system (Unique Recording 
System) was instituted across all participating NGOs to facilitate 
referral of KPs to specific target services, to maximize access and 
coverage, and to track performance in terms of risk behavior 
changes (condom and lubricant use, HIV/STI testing, counseling 
and referral) among the targeted KPs. In 2013, the number of 
NGOs participating in the grants program increased to 17, and in 
2014, the number increased to 24. Technical and administrative 
experts based in Managua traveled to all participating NGOs to 
provide one-on-one training, coaching, and mentorship on three 
to five occasions through the interventiion period. The NGOs 
were required to report data through the Unique Recording 
System, comply with administrative reporting, and remain in 
frequent communication throughout their involvement.
MaTerials anD MeThODs
study Design
This retrospective observational evaluation considered KPs cov-
ered by participating NGOs who received technical assistance 
from PrevenSida between 2012 and 2014. Variables of interest 
include the grants to each NGO for institutional strengthening 
and prevention activities between 2012 and 2014, the popula-
tion reached with prevention services by the NGOs, the propor-
tion of KPs reported to have changed their risk behavior, and 
estimated incidence of HIV in the population of interest from 
2010 to 2014.
sampling
The study population is all of the KPs receiving services from 
participating NGOs in each fiscal year (FY). NGOs were included 
if they received grants from PEPFAR and the Key Population 
Challenge Fund (a financing mechanism established to expand 
coverage of preventive services to hidden or hard-to-reach KPs) 
specifically for HIV prevention activities for KPs. Data on 100% 
of the universe is available from those NGOs: 12 NGOs in FY 
2012, 17 in FY2013, and 24 in FY2014.
Data collection
PrevenSida has an extensive database recording the preven-
tive services delivered by NGOs that uses an anonymous and 
FigUre 1 | Decision tree for the Prevensida cost-effectiveness evaluation.
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unique code for each service recipient to protect privacy. No 
additional information was required for this study – it was 
done entirely with the routine data collected through the 
Unique Recording System, including information by age, 
gender, population type, service received, number of contacts, 
geographical site where the service was delivered, and HIV 
test results. Other sources of information were PrevenSida’s 
financial records, which tracked grant payments to NGOs and 
staff costs for activities directly related to providing support 
to the NGOs. We used the project funder’s perspective for the 
analysis and therefore did not include the cost-sharing that 
was mandated for the NGOs.
Because of the anonymous nature of the data recording 
system and because no additional primary data were collected 
from clients or heath-care providers, the evaluation presented no 
risks to participants. The study was approved by the Centro de 
Investigaciones y Estudios de la Salud (CIES) of the Universidad 
Nacional Autónoma de Nicaragua (UNAN Managua).
analysis
To determine the efficiency of coverage of KPs, cost-effectiveness 
evaluation was conducted using decision-tree analysis com-
paring the PrevenSida intervention with business-as-usual 
(Figure 1). Inputs into the model in terms of the change in the 
risk of HIV were generated from the “Transmission Model” 
from UNAIDS (5), which used data from the PrevenSida 
records as inputs to estimate the number of individuals expected 
to develop HIV infection. Results were expressed in cost per 
additional person tested for HIV, cost per case of HIV infection 
averted, and cost per KP receiving services.
resUlTs
By 2014, 24 NGOs were receiving grants and technical assis-
tance as part of their involvement in PrevenSida with a total of 
74,080 people receiving their services (72,955 KPs plus 1,125 
confirmed HIV cases served by them). The total cost per per-
son in the key population reached was $11.32 with a range of 
$9.39–$16.55 per person depending on the region in which the 
NGO operated (Table 1).
We compared the cost of grants and administrative costs for 
technical assistance provided by PrevenSida between NGOs that 
had been working with the project for 3 years to those working 
for only 1  year. For comparability, they were chosen from the 
same regions. There was a difference in the number of people 
the NGOs were providing services to in the two categories, with 
the more experienced NGOs serving four or more times as many 
people in KPs. Therefore, the costs per capita for inexperienced 
Table 2 | grants and administrative costs for selected ngOs by region.
ngO region grants admin 
costs
People 
reached
admin cost 
per capita
Per capita 
total cost
experienced ngOs
A Central 33,902 5,864 6,766 0.87 5.88
B Pacific 33,502 8,712 4,695 1.86 8.99
C Pacific 33,098 8,712 4,076 2.14 10.26
inexperienced ngOs
F Central 16,634 5,864 1,318 4.45 17.07
D Pacific 15,452 8,712 2,001 4.35 12.08
E Pacific 11,074 8,712 784 11.11 25.24
Table 1 | costs and coverage of ngOs by Prevensida by region, 2014.
region ngOs Prevensida  
costs
cost per  
ngO ($)
grant  
total ($)
number reached cost per  
person  
reached   KP (at risk) PhiV
Caribbean 5 70,363 14,073 133,673 12,280 49 16.55
Pacific 14 121,962 8,712 349,205 44,049 1,076 10.44
Central 4 23,454 5,864 93,979 12,510 – 9.39
RSJ 1 18,763 18,763 26,918 4,116 – 11.10
Total 24 234,542 9,773 603,775 72,955 1,125 11.32
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sites were several times higher, both for the grants and for the 
PrevenSida administrative costs, even though the absolute costs 
were about half those of the experienced sites (Table  2). All 
costs were considered from the perspective of the funder of the 
PrevenSida Project.
The costs reported here do not include those related to the 
cost-sharing requirement of the participating NGOs. These 
amounted to $700,000 between 2012 and 2014. Approximately 
40% was as in-kind donations, 28% was for administrative and 
capital costs, such as rental of buildings and depreciation of 
vehicles, and the remaining 32% was for in-kind labor from 
volunteer staff. Sources for cost-share resources include the 
Global Fund for AIDS, TB and Malaria, UNAIDS, and other 
multilateral donors.
The inputs for the decision-tree model used to estimate cost-
effectiveness were obtained from the PrevenSida database directly 
or from the data used in the UNAIDS transmission model to 
estimate the number of new cases occurring before and after the 
PrevenSida intervention was operational (Table 3). These were 
entered into the model with binomial distributions correspond-
ing to the degree of uncertainty.
Outcomes were considered both in terms of HIV infections 
averted and DALYs averted. They were averaged for all of the 
recipients receiving service from providers who were part of 
the intervention. The latter were calculated using the standard 
method for burden of disease (9, 10) (Table 4).
Monte Carlo simulations were used to estimate the incre-
mental cost-effectiveness of the PrevenSida intervention in 2014 
compared to the situation for HIV prevention activities before 
PrevenSida began its work. The results are presented in 2014 
international dollars. Given that this analysis was conducted 
solely from the perspective of the funder of the PrevenSida 
Project, we did not include the cost of treating HIV/AIDS or 
other medical costs associated with the changes in behavior 
that may be attributed to prevention messages delivered due to 
PrevenSida.
The expected number of HIV cases averted due to reduction 
in risk behavior is 100 (95% CI: 8–175), and the expected number 
of DALYs averted with the PrevenSida strategy was about 1,340 
(95% CI: 768–1,954). The cost-effectiveness of the PrevenSida 
Project was estimated at $50,700 per case of HIV averted or 
$2,600 per DALY averted. Because of the uncertainty in the input 
variables, there was a 95% confidence interval between $1,000 
and $99,000 per case of HIV averted and between $50 and $5,100 
per DALY averted.
DiscUssiOn
The PrevenSida Project distributed about $600,000 in grants and 
spent about $230,000 to provide technical and administrative 
assistance to 24 HIV/AIDS NGOs throughout Nicaragua in 2014. 
In the same year, the number of individuals considered in KPs 
served by NGOs involved in the project was just over 72,955, 
for a total cost per individual served of less than $12, which 
is 0.26% of the Gross Domestic Product per capita (GDPPC). 
In terms of efficiency, the intervention cost approximately $2,600 
per DALY averted, which is a little over half the GDPPC and 
therefore is considered highly cost-effective according to WHO 
criteria for an efficient health intervention (12). The NGOs 
themselves organized and managed cost-sharing outside the 
PrevenSida mechanism, and these costs were not included in 
this cost-effectiveness analysis because the perspective was of 
the PrevenSida funder, USAID, and not the NGOs or society at 
large. The amount of cost-sharing was approximately $233,000 
per year; more than half of this amount was the utilization of 
volunteer labor and the share of office expenses in  situations 
where the NGO had negotiated shared office space in which to 
operate along with other organizations. This model was promoted 
by PrevenSida to develop a greater degree of engagement among 
the NGOs and to help develop a model for sustainability of 
the activities beyond the involvement of PrevenSida (personal 
communication; April 10, 2015).
Comparing the costs and efficiency in terms of spending per 
recipient of services, more experienced sites received a higher 
amount of absolute funding, but because they were providing 
services to substantially more individuals, they were a third to 
three times less costly per capita. The PrevenSida administrative 
costs were approximately the same per NGO receiving the techni-
cal assistance; therefore, the number of KPs the NGO provided 
Table 3 | Key epidemiological inputs for cost-effectiveness model.
Variable descriptions Value source
Probability of becoming HIV+ if risk behavior reduced, 2014 N 2,765 Comision Nicaraguense del SIDA (6)
D 3,265,000
Probability that KP gets NGO services, 2014 N 42,271 Comision Nicaraguense del SIDA (6)
D 80,280
Probability of risk behavior reduction when exposed to NGO, 2014 57% Instituto Nacional de informacion de desarrollo (7)
Probability of HIV infection if no change in risk behavior in KP N 3,387 Comision Nicaraguense del SIDA (6) and PrevenSIDA (8)
D 3,265,000
Probability of risk behavior reduction if KP not exposed to NGO, 2014 38% Comision Nicaraguense del SIDA (6); PrevenSIDA (8), and UNAIDS (5)
Comision Nicaraguense del SIDA (6)
Probability that KP gets NGO services, 2010 N 3,065 Comision Nicaraguense del SIDA (6) and UNAIDS (5)
D 74,280 Comision Nicaraguense del SIDA (6)
Probability of reduced risk behavior with NGO, 2010 38% UNAIDS (5)
N, numerator; D, denominator.
Table 4 | sources and results for DalY calculations.
Description hiV with arT hiV with no arT aiDs with no arT reference
Discount rate 0.03 0.03 0.03 Assumed
Disability weight (1 for death) 0.053 0.221 0.547 Mather et al. (10), Salomon et al. (11), Comision Nicaraguense 
del SIDA (6), and USAID Nicaragua (4)
Age at death (YLL) 60 36 36 Comision Nicaraguense del SIDA (6) and USAID Nicaragua (4)
Life expectancy at age of death 21 42 42 Comision Nicaraguense del SIDA (6) and USAID Nicaragua (4)
Years between onset and death 30 10 2 Comision Nicaraguense del SIDA (6) and USAID Nicaragua (4)
Age at onset 26 26 26 Comision Nicaraguense del SIDA (6) and USAID Nicaragua (4)
Years with disability 30 8 2 Mather et al. (10) and Salomon et al. (11)
Years of life lost 4.58 18.88 24.00 Calculated
Years of life lost to disability 1.41 2.35 1.61 Calculated
DALYs lost 5.98 21.23 25.61 Calculated
Percent of people with HIV in group 67 33 33 Calculated
DALYs lost overall illness 4.01 7.01 8.45 Calculated
Total estimated DALY burden per case of HIV in Nicaragua 19.46 Calculated
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services to was the main driver of the efficiency of their program. 
Given that the larger NGOs were the first to be included in the 
project, they look more efficient. Some of the technical assistance 
provided by PrevenSida was to improve management capacity in 
the NGO, and it was seen that fewer inputs were required over 
time for this type of assistance. It can be expected that if other 
NGOs providing services to KPs are added to the program in 
the future, they will appear less efficient because they will likely 
be serving fewer individuals in KPs and require more capacity-
building inputs than NGOs already part of the project. However, 
both equity and efficiency issues should be addressed when 
implementing programs aimed at HIV services because always 
deferring to efficiency may lead to greater and more problematic 
inequities (13).
The cost and efficiency of the combination prevention model 
as implemented by NGOs receiving support from PrevenSida 
varied substantially by region, again more as a reflection of the 
number of people in KPs that the NGOs were providing services 
for. The five NGOs in the Caribbean Region served about 10,000 
people in KPs using grants totaling about $134,000, while the four 
in the Central Region served 20% more people with 42% less in 
grant funding. However, the biggest difference was in the cost of 
providing administrative and technical support, which was three 
times as much in the Caribbean Region as in the Central. Again, 
the issue of equity versus efficiency must be considered when 
making decisions in light of these data.
This study had limitations, some common to economic and 
epidemiological modeling and some due to data deficiencies. 
Several assumptions were made with the cost-effectiveness 
model. The discount rate of 3% per year is standard in this type 
of analysis. It could be argued that age weighting should have 
been used to account for the fact that the highest incidence of 
HIV occurs in those who are generally the most productive and 
therefore have the highest DALY age weighting. Doing so would 
have improved the cost-effectiveness of the project; instead, we 
produced a more conservative estimate. We assumed that those 
members of KPs who received services from the NGOs cost 
approximately the same regardless of their age, although this may 
not have been the case in reality. We also assumed that the new 
cases averted due to the intervention would have occurred at the 
same average age of those who have so far contracted HIV in 
Nicaragua. However, it is unlikely this input would have much of 
a difference in the overall result. Many figures used in the cost-
effective model were based on epidemiological estimates using 
6Broughton et al. HIV Services in Nicaragua: Evaluation
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calculations given by UNAIDS. While these are widely used in 
such projections, it would have been preferable to have enough 
follow-up time to collect actual outcome data.
cOnclUsiOn
The technical support given by PrevenSida appears to be cost-
effective by WHO standards compared to the status quo, and 
therefore we recommend that implementation of this form of 
capacity development be continued. While it appears to be less 
efficient for new NGOs that provide services to fewer people in 
KPs, it is still likely to be cost-effective by international standards. 
These findings show that such targeted capacity development 
interventions aimed at organizations that provide services to KPs 
where the HIV epidemic has the greatest effect can be acceptably 
efficient, at least in this setting.
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